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EX527 induces an increase in acetylation of H3K9 but decrease
overall methylation.
Conclusions: The results of our work indicate for the first
time that PFD can regulate epigenetic marks possibly through
modulation of the PPAR-SIRT1-DNMT1 axis. Acetylation in H3K9
decreases with PFD treatment, however overall methylation
increases. The perspectives of this work will be to analyze the
methylation of specific genes (PPARalpha, IL-6, TNFalpha) involved
in the development of liver diseases.
This work was partially subsidized by CONACyT basic science
259096 CB-2015-01, CONACyT No. 658152
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Background and aim: The increase in NASH prevalence coin-
cides with the current obesity pandemic. Obesity is characterized
by a state of chronic inflammation with oxidative stress in adi-
pose tissue and liver. A high fat/sugar diet can induce non-alcoholic
steatohepatitis, which is characterized by inflammation, hepato-
cyte swelling, and steatosis. To assess molecular, histological, and
biochemical changes in a murine NASH model subjected to a high-
fat diet for 16 weeks.
Material and methods: Male mice 4-5 weeks old, C57BL / 6J
were fed a high-fat diet (HF, 60% fat, 42gr / L sugars in water) for
16 weeks. Every 4 weeks 4 mice were sacrificed for a follow-up of
the model at 4, 8, 12 and 16 weeks. Serum glucose was measured
after 4 hours of fasting, animal weight and caloric intake. The liver
was removed and weighed, as was the epididymal adipose tissue.
AST, ALT, TAG, Chol and VLDL were measured. Immunohistochem-
istry was performed for -SMA and hematoxylin-eosin staining,
Masson’s trichrome and Syrian red. The hepatic expression of IL-
6, TNF, COL1A1 and TGF- mRNAs was determined by qRT-PCR.
Quantitative variables were analyzed with ANOVA, Tukey for para-
metric data and Kruskal-Wallis for non-parametric data. Opinion
CI00518 of ethics and investigation committee.
Results: Animals at week 16 showed high body weight com-
pared to animals with standard diet, presence of steatosis and liver
inflammation (p < 0.05). Serum glucose increased at week 12 and
16 (p < 0.05). The weight of the liver and epididymal fat increases
as the model is established, without achieving statistical signifi-
cance. The histological parameters coincide with the establishment
of a steatohepatitis, while the values of the biochemical parameters
increase remarkably compared to the control group. Inflammatory
and fibrotic genes increase at 16 weeks compared to the control
group.
Conclusions: Exposure to a diet high in fat and simple sug-
ars induced increased body weight, steatohepatitis, inflammation,
hyperglycemia, and increased expression of liver enzymes and
genes involved in inflammation and fibrosis.
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Background and aim: In order to reduce mortality on wait-
ing list, therapeutic strategies are required to increase the use of
steatotic liver grafts in transplantation. However, steatotic grafts
tolerate poorly ischemia-reperfusion (I/R) injury, and therefore
they show a very high risk to early allograft dysfunction or primary
nonfunction after transplantation. The aim of the present research
was to evaluate the potential of 3 pharmacological modulators of
lipid metabolism to induce defatting and protection against hepatic
damage during cold preservation period in steatotic liver grafts.
Material and methods: Wistar rats were fed with a high-fat
diet to induce steatosis. Then, steatotic livers were preserved at 4◦
C for 6 hours, either in Custodiol preservation solution, or in Cus-
todiol solution enriched with caffeine, choline, or l-carnitine. At
the end of this period, grafts were washed-out and transaminases
and triglycerides in liver tissue were determined. This study was
approved by the institutional Research Ethics Committee.
Results: Addition of caffeine to Custodiol solution decreased
hepatic triglycerides content by 56% in steatotic grafts when com-
pared with grafts preserved only in Custodiol. Triglycerides content
was similar in steatotic grafts preserved in Custodiol enriched with
choline or l-carnitine, and in those grafts preserved in Custodiol
without additives. Regarding liver injury, preservation in Custo-
diol supplemented with caffeine, choline or l-carnitine resulted in
a decrease in transaminases, compared to the levels observed in
preservation with solely Custodiol.
Conclusions: Addition of caffeine to preservation solution trig-
ger defatting in steatotic liver grafts, which is associated with
protection against I/R injury. The enrichment of preservation solu-
tion with choline or l-carnitine decrease I/R injury in steatotic
grafts, but this effect was not related to reduction in triglyceride
content.
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Background and aim: Ischemia-reperfusion (IR) injury is one
of the leading causes of early graft dysfunction in liver transplan-
tation. Techniques such as ischemic preconditioning protect the
graft through the activation of the hypoxia-inducible factors, which
are the main regulators of oxygen homeostasis and are downreg-
ulated by the EGLN prolyl-hydroxylases. The inhibition of EGLN
has a therapeutic effect against IR injury. Our aim was to evalu-
ate the effect of the EGLN inhibitor sodium (S)-2-hydroxyglutarate
[(S)-2HG] against liver IR injury in Wistar rats.
Material and methods: (S)-2HG was synthesized from L-
glutamic acid by diazotization/alkaline hydrolysis, and its structure
was confirmed by nuclear magnetic resonance. Thirty-one female
Wistar rats were used, weighing 250 – 300 g, randomly divided
in the following groups, following the specifications of the
NOM-062-ZOO-1999: IR (n = 7, ischemia: 20 minutes, reperfusion:
Figure. Liver injury and inflammatory biomarkers. (A) Serum alanine aminotrans-
ferase; (B) Serum aspartate aminotransferase; (C) Serum lactate dehydrogenase; (D)
Serum glucose; (E) Tissue interleukin 1; (F) Tissue interleukin 6. One-way ANOVA
with Tukey post hoc test, *p < 0.05 versus SH; #p < 0.05 versus IR.
60 minutes), sham (SH, n = 7, laparotomy without IR), non-toxicity
(HGTox, n = 6, 25 mg/kg, p.o., twice per day for two days, laparo-
tomy without IR), and (S)-2HG + IR (HGIR, n = 7, same dose as HGTox
group + IR induction). Serum levels of ALT, AST, LDH, ALP, glucose,
and total bilirubin, were assessed. Tissue levels of IL-1, IL-6, TNF-
, malondialdehyde, SOD, and glutathione peroxidase were also
evaluated. This project was approved by the Ethics and Research
Committee of our institution (Registration number: HI19-00003).
Results: A difference in the levels of ALT, AST, LDH, glucose,
IL-1, and IL-6 was observed among the groups (Figure). No hep-
atotoxic effect was observed when comparing the HGTox group
versus the SH group. There were also no differences in the other
biomarkers assessed.
Conclusions: (S)-2HG showed a hepatoprotective effect,
decreasing the levels of liver injury and inflammation biomarkers.
No hepatotoxic effect was observed at the tested dose.
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Background and aim: Hepatocellular carcinoma (HCC) is a pri-
mary neoplasm of the liver with high recurrence and high mortality
rate. The etiological factors are hepatitis B and/or C virus infections,
non-alcoholic steatohepatitis, alcohol consumption, and aflatoxin
b1 exposition. These factors promote inflammation, fibrosis, and
cirrhosis, and alter the expression of genes and molecular mech-
anisms, initiating hepatocarcinogenesis. The modified resistant
hepatocyte model (MRHM) has been established which simulates
the stages of carcinogenesis. Pirfenidone (PFD) has shown antifi-
brotic, anti-inflammatory and antioxidant effects in liver damage
models, so the aim was to evaluate the administration of PFD on
histopathological alterations and the expression of key proteins in
the development of hepatocarcinogenesis in MHRM.
Material and methods: Longitudinal experimental study. 30
Wistar rats were divided into 3 groups: control group, carcinogenic
damage group, and carcinogenic damage group plus daily admin-
istration of PFD. The physical and clinical data of the animals were
analyzed at 30 days. All tissues were subjected to H&E, and Mas-
son trichrome histological assays, and analysis of proteins involved
in liver fibrosis, acute and chronic inflammation, apoptosis, cell
division, tumor promotion/suppression, and cell metabolism using
Western-Blot tests and microscopy confocal. Experiments for trip-
licate were performed; data were analyzed and plotted in GraphPad
Prism 7.
Results: Morphological analysis: damage group shows dense,
pale brown and inflamed livers compared to control and PFD
groups. PFD administration prevents damage in the hepatocyte
architecture, reduces periportal fibrosis and prevents inflamma-
tion overexpression markers (NFkB, IL-6, and TNFalpha) and cell
